Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial seems to be focused on training residents to use a specific ultrasound technique called VExUS to assess fluid overload — does that mean I would primarily be helping train doctors rather than receiving an experimental treatment myself, and how would that affect my care?
2. 2Since the main thing being measured is the quality of ultrasound images taken by residents-in-training, would my diagnosis and treatment decisions be guided by these trainee assessments, and would an experienced physician also be reviewing my results independently?
3. 3I have acute heart failure with fluid congestion — would my doctor consider this trial a good fit for my current condition, or would standard approaches to managing my fluid levels be a better first step before involving a training program?
4. 4Since this trial has no assigned phase (listed as 'NA'), which usually means it's more of an educational or feasibility study rather than a drug or device test, can my doctor explain exactly what risks or benefits I should realistically expect from participating?
5. 5If a resident's VExUS ultrasound assessment of my venous congestion turns out to be inaccurate during the training process, what safeguards are in place to make sure my treatment plan isn't negatively affected?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.